rmc

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑added cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC‑6236), a RAS(ON) multi‑selective...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

OverviewAmentum is seeking a highly skilled Combat Systems SPY Technician to join our team in Rota, Spain, supporting the Forward Deployed Regional Maintenance Center (FDRMC). This role offers a unique opportunity to directly support the readiness of forward-deployed U.S. Navy forces by maintaining and restoring critical radar and combat...

OverviewAmentum is seeking a highly skilled Combat Systems SPY Technician to join our team in Rota, Spain, supporting the Forward Deployed Regional Maintenance Center (FDRMC). This role offers a unique opportunity to directly support the readiness of forward-deployed U.S. Navy forces by maintaining and restoring critical radar and combat...

Amentum is seeking a highly skilled Combat Systems SPY Technician to join our team in Rota, Spain, supporting the Forward Deployed Regional Maintenance Center (FDRMC). This role offers a unique opportunity to directly support the readiness of forward-deployed U.S. Navy forces by maintaining and restoring critical radar and combat systems. As part of a...

Marine Gas Turbine Inspector (MGTI) – Rota, SpainAmentum is seeking a certified Marine Gas Turbine Inspector (MGTI) to join our team in Rota, Spain, supporting the Forward Deployed Regional Maintenance Center (FDRMC). This is a unique opportunity to play a critical role in sustaining the operational readiness of U.S. Navy forward‑deployed forces in the...

OverviewAmentum is seeking a highly skilled Combat Systems SPY Technician to join our team in Rota, Spain, supporting the Forward Deployed Regional Maintenance Center (FDRMC). This role offers a unique opportunity to directly support the readiness of forward-deployed U.S. Navy forces by maintaining and restoring critical radar and combat...

OverviewAmentum is seeking a highly skilled Combat Systems SPY Technician to join our team in Rota, Spain, supporting the Forward Deployed Regional Maintenance Center (FDRMC). This role offers a unique opportunity to directly support the readiness of forward-deployed U.S. Navy forces by maintaining and restoring critical radar and combat...

Marine Gas Turbine Inspector (MGTI) – Rota, Spain Amentum is seeking a certified Marine Gas Turbine Inspector (MGTI) to join our team in Rota, Spain, supporting the Forward Deployed Regional Maintenance Center (FDRMC). This is a unique opportunity to play a critical role in sustaining the operational readiness of U.S. Navy forward‑deployed forces in the...

Amentum is seeking a highly skilled Combat Systems SPY Technician to join our team in Rota, Spain, supporting the Forward Deployed Regional Maintenance Center (FDRMC). This role offers a unique opportunity to directly support the readiness of forward-deployed U.S. Navy forces by maintaining and restoring critical radar and combat systems. As part of a...